Free Trial

Akero Therapeutics (AKRO) Insider Trading & Ownership

Akero Therapeutics logo
$29.34 +0.94 (+3.31%)
(As of 12/20/2024 05:15 PM ET)

Akero Therapeutics (NASDAQ:AKRO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.94%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$24.25 M
Get AKRO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Akero Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AKRO Insider Buying and Selling by Quarter

Akero Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/16/2024Catriona YaleInsiderSell9,074$29.11$264,144.14  
12/16/2024Patrick LamyVPSell1,000$29.13$29,130.00  
12/10/2024Andrew ChengCEOSell7,855$30.79$241,855.45  
12/10/2024Jonathan YoungCOOSell2,503$30.79$77,067.37  
12/10/2024Patrick LamyVPSell925$30.79$28,480.75  
12/10/2024Timothy RolphInsiderSell4,818$30.91$148,924.38  
12/10/2024William Richard WhiteCFOSell2,817$30.79$86,735.43  
12/2/2024Andrew ChengCEOSell25,000$32.09$802,250.00  
12/2/2024Jonathan YoungCOOSell10,000$32.13$321,300.00  
11/15/2024Catriona YaleInsiderSell9,061$27.73$251,261.53  
11/1/2024Andrew ChengCEOSell108,366$31.73$3,438,453.18  
11/1/2024Catriona YaleInsiderSell15,485$32.62$505,120.70  
11/1/2024Jonathan YoungCOOSell50,716$31.57$1,601,104.12  
10/30/2024Catriona YaleInsiderSell4,515$32.53$146,872.95  
10/18/2024Andrew ChengCEOSell63,539$31.53$2,003,384.67  
10/16/2024Andrew ChengCEOSell24,992$31.14$778,250.88  
10/14/2024Catriona YaleInsiderSell6,136$30.03$184,264.08  
10/14/2024Jonathan YoungCOOSell40,000$30.15$1,206,000.00  
10/1/2024Jonathan YoungCOOSell10,000$28.18$281,800.00  
9/20/2024Catriona YaleInsiderSell5,500$27.65$152,075.00  
9/18/2024Catriona YaleInsiderSell3,871$27.56$106,684.76  
9/16/2024Catriona YaleInsiderSell2,485$27.52$68,387.20  
9/10/2024Andrew ChengCEOSell1,738$26.18$45,500.84  
9/10/2024Catriona YaleInsiderSell637$26.18$16,676.66  
9/10/2024Jonathan YoungCOOSell568$26.18$14,870.24  
9/10/2024William Richard WhiteCFOSell639$26.18$16,729.02  
8/26/2024Catriona YaleInsiderSell5,200$27.51$143,052.00  
8/26/2024William Richard WhiteCFOSell75,159$27.21$2,045,076.39  
8/23/2024Catriona YaleInsiderSell8,851$27.53$243,668.03  
8/1/2024Jonathan YoungCOOSell5,000$26.75$133,750.00  
7/24/2024William Richard WhiteCFOSell139,083$26.98$3,752,459.34  
7/16/2024William Richard WhiteCFOSell34,811$28.04$976,100.44  
7/1/2024Jonathan YoungCOOSell5,000$23.40$117,000.00  
6/11/2024Andrew ChengCEOSell7,894$22.64$178,720.16  
6/11/2024Catriona YaleInsiderSell2,825$22.64$63,958.00  
6/11/2024Jonathan YoungCOOSell2,516$22.64$56,962.24  
6/11/2024Patrick LamyVPSell569$22.64$12,882.16  
6/11/2024William Richard WhiteCFOSell2,831$22.64$64,093.84  
6/3/2024Jonathan YoungCOOSell5,000$19.29$96,450.00  
5/1/2024Jonathan YoungCOOSell5,000$20.15$100,750.00  
This Crypto Is Set to Explode in December (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

4/1/2024Jonathan YoungCOOSell5,000$24.38$121,900.00  
3/4/2024Andrew ChengCEOSell75,000$32.87$2,465,250.00  
3/4/2024Catriona YaleInsiderSell20,646$35.49$732,726.54  
12/27/2023Jonathan YoungCOOSell5,414$24.00$129,936.00  
(Data available from 1/1/2013 forward)

AKRO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Akero Therapeutics includes Andrew Cheng, Catriona Yale, G. Walmsley Graham, Jonathan Young, Patrick Lamy, Seth Loring Harrison, Skorpios Trust, Timothy Rolph, Tomas J. Heyman, and William Richard White. Learn more on insiders at AKRO.

7.94% of Akero Therapeutics stock is owned by insiders. Learn more on AKRO's insider holdings.

The following insider purchased AKRO shares in the last 24 months: G. Walmsley Graham ($11,281,700.00).

Insiders have purchased a total of 350,000 AKRO shares in the last 24 months for a total of $11,281,700.00 bought.

The following insiders have sold AKRO shares in the last 24 months: Andrew Cheng ($21,008,194.25), Catriona Yale ($4,853,996.38), Jonathan Young ($5,892,769.09), Patrick Lamy ($70,492.91), Timothy Rolph ($4,545,796.82), Tomas J. Heyman ($1,421,420.00), and William Richard White ($8,211,565.90).

Insiders have sold a total of 1,290,992 Akero Therapeutics shares in the last 24 months for a total of $46,004,235.35 sold.

Akero Therapeutics Key Executives

  • Dr. Andrew Cheng M.D. (Age 57)
    Ph.D., President, CEO & Director
    Compensation: $1.04M
  • Dr. Jonathan M. Young J.D. (Age 54)
    Ph.D., Co-Founder, Executive VP, COO & Secretary
    Compensation: $672.35k
  • Dr. Timothy Rolph (Age 70)
    Co-Founder & Chief Scientific Officer
    Compensation: $722.32k
    1 recent trades
  • Mr. William R. White J.D. (Age 51)
    Executive VP, CFO, Treasurer & Head of Corporate Development
    Compensation: $678.06k
  • Ms. Catriona  YaleMs. Catriona Yale (Age 52)
    Executive VP & Chief Development Officer
    Compensation: $678.06k
    11 recent trades
  • Mr. Scott A. Gangloff (Age 50)
    Chief Technical Officer
  • Mr. David West J.D.
    Vice President of Legal
  • Mr. John J. Schembri (Age 62)
    Vice President & Head of Finance
  • Mr. Patrick Lamy (Age 51)
    Senior Vice President of Commercial Strategy
    2 recent trades


This page (NASDAQ:AKRO) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners